Support the Uppsala Fund
and keep your donation in Sweden.
A message to our friends in Sweden.
Open Medicine Foundation (OMF) is very happy to support our Chief Medical Officer Dr. Jonas Bergquist and his cutting-edge work at the ME/CFS Collaborative Research Center (CRC) at Uppsala University, during Triple Giving November.
Donate to “The Uppsala Fund” during Triple Giving November and keep your gift in Sweden! Donations received during Triple Giving November are matched by OMF’s most generous donor, supporting research around the world.
2024 Research and Publications from Uppsala
- The LIFT
- Abujrais, S., Vallianatou, T., and Bergquist, J. (2024). Untargeted Metabolomics and Quantitative Analysis of Tryptophan Metabolites in Myalgic Encephalomyelitis Patients and Healthy Volunteers: A Comparative Study Using High-Resolution Mass Spectrometry. ACS Chem. Neurosci. doi:10.1021/acschemneuro.4c00444 (Collaborative Center at Uppsala)
- Read a summary of the paper here.
- Abujrais, S., Ubhayasekera, S.J.K.A., and Bergquist, J. (2024). Analysis of tryptophan metabolites and related compounds in human and murine tissue: development and validation of a quantitative and semi-quantitative method using high resolution mass spectrometry. Anal. Methods, 16, 1074-1082. doi:10.1039/d3ay01959d (Collaborative Center at Uppsala)
- Read a summary of the paper here.
About the research center
Established in 2019, this research center is directed by Jonas Bergquist, MD, PhD. Prior to this new center, Dr. Bergquist had already been researching ME/CFS for nearly a decade. Dr. Bergquist and his lab develop novel methods for extracting patient samples and measuring the metabolites and proteins within those samples.
They then apply these methods to produce unique and valuable data from a range of diseases. Along with ME/CFS, his lab has a general interest in neurodegenerative diseases such as Parkinson’s, Alzheimer’s, amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS).
The ME/CFS CRC at Uppsala University is looking for ME/CFS biomarkers to develop a diagnostic test and to contribute to the understanding of what initiates the disease process. Not only are they looking for single metabolites or proteins, but they are also looking for the pattern of all the data the extract from ME/CFS patient samples and are working towards a defining biochemical signature of the disease.
This collaborative research initiative is looking to develop methods to measure proteins, peptides and metabolites in the blood and cerebrospinal fluid of ME/CFS patients to help define the underlying biological cause, to form a diagnostic and to ultimately find treatments for the disease.
Please support The Uppsala Fund at Open Medicine Foundation. Donations made through December 3 will be tripled by generous donors and support OMF’s global research initiatives. And your donation goes directly to the Uppsala CRC!
To learn more about research in Uppsala, visit Uppsala ME/CFS Research Center.